Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence.
mesenchymal stem cells
neuroinflammation
opiod addiction
secretome
withdrawal
Journal
CNS neuroscience & therapeutics
ISSN: 1755-5949
Titre abrégé: CNS Neurosci Ther
Pays: England
ID NLM: 101473265
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
revised:
21
09
2023
received:
31
07
2023
accepted:
12
10
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
aheadofprint
Résumé
Morphine is an opiate commonly used in the treatment of moderate to severe pain. However, prolonged administration can lead to physical dependence and strong withdrawal symptoms upon cessation of morphine use. These symptoms can include anxiety, irritability, increased heart rate, and muscle cramps, which strongly promote morphine use relapse. The morphine-induced increases in neuroinflammation, brain oxidative stress, and alteration of glutamate levels in the hippocampus and nucleus accumbens have been associated with morphine dependence and a higher severity of withdrawal symptoms. Due to its rich content in potent anti-inflammatory and antioxidant factors, secretome derived from human mesenchymal stem cells (hMSCs) is proposed as a preclinical therapeutic tool for the treatment of this complex neurological condition associated with neuroinflammation and brain oxidative stress. Two animal models of morphine dependence were used to evaluate the therapeutic efficacy of hMSC-derived secretome in reducing morphine withdrawal signs. In the first model, rats were implanted subcutaneously with mini-pumps which released morphine at a concentration of 10 mg/kg/day for seven days. Three days after pump implantation, animals were treated with a simultaneous intravenous and intranasal administration of hMSC-derived secretome or vehicle, and withdrawal signs were precipitated on day seven by i.p. naloxone administration. In this model, brain alterations associated with withdrawal were also analyzed before withdrawal precipitation. In the second animal model, rats voluntarily consuming morphine for three weeks were intravenously and intranasally treated with hMSC-derived secretome or vehicle, and withdrawal signs were induced by morphine deprivation. In both animal models secretome administration induced a significant reduction of withdrawal signs, as shown by a reduction in a combined withdrawal score. Secretome administration also promoted a reduction in morphine-induced neuroinflammation in the hippocampus and nucleus accumbens, while no changes were observed in extracellular glutamate levels in the nucleus accumbens. Data presented from two animal models of morphine dependence suggest that administration of secretome derived from hMSCs reduces the development of opioid withdrawal signs, which correlates with a reduction in neuroinflammation in the hippocampus and nucleus accumbens.
Sections du résumé
BACKGROUND
BACKGROUND
Morphine is an opiate commonly used in the treatment of moderate to severe pain. However, prolonged administration can lead to physical dependence and strong withdrawal symptoms upon cessation of morphine use. These symptoms can include anxiety, irritability, increased heart rate, and muscle cramps, which strongly promote morphine use relapse. The morphine-induced increases in neuroinflammation, brain oxidative stress, and alteration of glutamate levels in the hippocampus and nucleus accumbens have been associated with morphine dependence and a higher severity of withdrawal symptoms. Due to its rich content in potent anti-inflammatory and antioxidant factors, secretome derived from human mesenchymal stem cells (hMSCs) is proposed as a preclinical therapeutic tool for the treatment of this complex neurological condition associated with neuroinflammation and brain oxidative stress.
METHODS
METHODS
Two animal models of morphine dependence were used to evaluate the therapeutic efficacy of hMSC-derived secretome in reducing morphine withdrawal signs. In the first model, rats were implanted subcutaneously with mini-pumps which released morphine at a concentration of 10 mg/kg/day for seven days. Three days after pump implantation, animals were treated with a simultaneous intravenous and intranasal administration of hMSC-derived secretome or vehicle, and withdrawal signs were precipitated on day seven by i.p. naloxone administration. In this model, brain alterations associated with withdrawal were also analyzed before withdrawal precipitation. In the second animal model, rats voluntarily consuming morphine for three weeks were intravenously and intranasally treated with hMSC-derived secretome or vehicle, and withdrawal signs were induced by morphine deprivation.
RESULTS
RESULTS
In both animal models secretome administration induced a significant reduction of withdrawal signs, as shown by a reduction in a combined withdrawal score. Secretome administration also promoted a reduction in morphine-induced neuroinflammation in the hippocampus and nucleus accumbens, while no changes were observed in extracellular glutamate levels in the nucleus accumbens.
CONCLUSION
CONCLUSIONS
Data presented from two animal models of morphine dependence suggest that administration of secretome derived from hMSCs reduces the development of opioid withdrawal signs, which correlates with a reduction in neuroinflammation in the hippocampus and nucleus accumbens.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1200287
Organisme : Ministerio de Ciencias e Innovación España
ID : PID2019-109823RB-100/MICINN/AEI/10.13039/501100011033
Organisme : Ministerio de Ciencias e Innovación España
ID : 21212198
Informations de copyright
© 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Références
The Lancet Public Health. Opioid overdose crisis: time for a radical rethink. Lancet Public Health. 2022;7:e195.
Ghose R, Forati AM, Mantsch JR. Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis. J Urban Health. 2022;99(2):316-327.
Centers for Disease Control and Prevention. US overdose deaths in 2021 increased half as much as in 2020-but are still up 15%. 2022.
Degenhardt L, Grebely J, Stone J, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560-1579.
van Amsterdam J, Pierce M, van den Brink W. Is Europe facing an emerging opioid crisis comparable to the U.S.? Ther Drug Monit. 2021;43(1):42-51.
McAuley A, Fraser R, Glancy M, et al. Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011-20: a national retrospective cohort study. Lancet Public Health. 2023;8(7):e484-e493.
National Service for the Prevention and Rehabilitation of Drug and Alcohol Use. SENDA CHILE. 2017. Accessed January 12, 2023. https://www.senda.gob.cl/wp-content/uploads/2019/01/ENPE-2017.pdf
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624-1645.
Shah M, Huecker MR. Opioid Withdrawal. In: [Updated 2023 Apr 29]. In: StatPearls. StatPearls Publishing 2023. Accessed May 22, 2023. https://www.ncbi.nlm.nih.gov/books/NBK526012/2023
Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence. J Pharmacol Exp Ther. 2019;371(2):422-452.
Gipson CD, Dunn KE, Bull A, Ulangkaya H, Hossain A. Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female rats. Exp Clin Psychopharmacol. 2021;29(6):636-649.
Blum J, Gerber H, Gerhard U, et al. Acute effects of heroin on emotions in heroin-dependent patients. Am J Addict. 2013;22(6):598-604.
Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. Lancet. 2019;393(10182):1760-1772.
Burma NE, Kwok CH, Trang T. Therapies and mechanisms of opioid withdrawal. Pain Manag. 2017;7(6):455-459.
Cuitavi J, Hipolito L, Canals M. The life cycle of the mu-opioid receptor. Trends Biochem Sci. 2021;46(4):315-328.
Gray AM. The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in vivo cerebral microdialysis and behavioural study. Eur Neuropsychopharmacol. 2002;12(3):245-254.
Evans CJ, Cahill CM. Neurobiology of opioid dependence in creating addiction vulnerability. F1000Res. 2016;5:5.
LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28(12):3170-3177.
Leventelis C, Goutzourelas N, Kortsinidou A, et al. Buprenorphine and methadone as opioid maintenance treatments for heroin-addicted patients induce oxidative stress in blood. Oxid Med Cell Longev. 2019;2019:1-9.
Jia J, Xu G, Zeng X. The biology of morphine and oxidative stress. Handbook of Substance Misuse and Addictions: From Biology to Public Health. Springer; 2022:1955-1975.
Re G-F, Jia J, Xu Y, et al. Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal. Int Immunopharmacol. 2022;107:108696.
Xu B, Wang Z, Li G, et al. Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin Pharmacol Toxicol. 2006;99(2):153-161.
Cai Y, Yang L, Hu G, et al. Regulation of morphine-induced synaptic alterations: role of oxidative stress, ER stress, and autophagy. J Cell Biol. 2016;215(2):245-258.
Cuitavi J, Andres-Herrera P, Meseguer D, et al. Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: alterations induced by inflammatory pain. Glia. 2023;71(8):1906-1920.
Wang X, Loram LC, Ramos K, et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci. 2012;109(16):6325-6330.
Quintanilla ME, Quezada M, Morales P, et al. Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence. Transl Psychiatry. 2022;12(1):462.
Berríos-Cárcamo P, Quezada M, Quintanilla ME, et al. Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants. 2020;9(9):830.
Lovell MA, Bradley MA, Fister SX. 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. J Alzheimers Dis. 2012;32(1):139-146.
Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci. 1998;19(8):328-334.
Gipson CD, Rawls S, Scofield MD, Siemsen BM, Bondy EO, Maher EE. Interactions of neuroimmune signaling and glutamate plasticity in addiction. J Neuroinflammation. 2021;18(1):1-23.
Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci. 2014;34(16):5649-5657.
Saeedi N, Darvishmolla M, Tavassoli Z, et al. The role of hippocampal glial glutamate transporter (GLT-1) in morphine-induced behavioral responses. Brain Behav. 2021;11(9):e2323.
Dahan A. Opioid-induced respiratory effects: new data on buprenorphine. Palliat Med. 2006;20(8_suppl):3-8.
Kosten TR, Baxter LE. Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment. Am J Addict. 2019;28(2):55-62.
Lindvall O, Barker RA, Brüstle O, Isacson O, Svendsen CN. Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell. 2012;10(2):151-155.
Jezierska-Wozniak K, Sinderewicz E, Czelejewska W, Wojtacha P, Barczewska M, Maksymowicz W. Influence of bone marrow-derived mesenchymal stem cell therapy on oxidative stress intensity in minimally conscious state patients. J Clin Med. 2020;9(3):683.
Ezquer F, Quintanilla ME, Morales P, et al. Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse-like drinking in high-alcohol drinker rats. Addict Biol. 2019;24(1):17-27.
De Gregorio C, Contador D, Díaz D, et al. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice. Stem Cell Res Ther. 2020;11:1-21.
Quintanilla ME, Ezquer F, Morales P, et al. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Res Ther. 2019;10(1):205.
Meyerrose T, Olson S, Pontow S, et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev. 2010;62(12):1167-1174.
Farfan N, Carril J, Redel M, et al. Intranasal administration of mesenchymal stem cell secretome reduces hippocampal oxidative stress, neuroinflammation and cell death, improving the behavioral outcome following perinatal asphyxia. Int J Mol Sci. 2020;21(20):1-27.
Ni H, Yang S, Siaw-Debrah F, et al. Exosomes derived from bone mesenchymal stem cells ameliorate early inflammatory responses following traumatic brain injury. Front Neurosci. 2019;13:14.
Tang J, Kang Y, Zhou Y, et al. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Res Bull. 2023;202:110760.
Berríos-Cárcamo P, Quezada M, Santapau D, et al. A novel morphine drinking model of opioid dependence in rats. Int J Mol Sci. 2022;23(7):3874.
Alexander BK, Coambs RB, Hadaway PF. The effect of housing and gender on morphine self-administration in rats. Psychopharmacology (Berl). 1978;58(2):175-179.
Cicero TJ, Aylward SC, Meyer ER. Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav. 2003;74(3):541-549.
Mohammadian J, Najafi M, Miladi-Gorji H. Effect of enriched environment during adolescence on spatial learning and memory, and voluntary consumption of morphine in maternally separated rats in adulthood. Dev Psychobiol. 2019;61(4):615-625.
McLane VD, Bergquist I, Cormier J, et al. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: plasma concentration, analgesia, and naloxone-precipitated withdrawal. Life Sci. 2017;185:1-7.
Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Rubinstein KJ. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. J Pharmacol Exp Ther. 1992;260(1):355-363.
Gellert V, Holtzman S. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther. 1978;205(3):536-546.
Liu J, Pan H, Gold MS, Derendorf H, Bruijnzeel AW. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats. Neuropharmacology. 2008;55(5):812-818.
Oses C, Olivares B, Ezquer M, et al. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: potential application in the treatment of diabetic neuropathy. PLoS One. 2017;12(5):e0178011.
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 2022;23(17):1-17.
Gangadaran P, Oh EJ, Rajendran RL, et al. Three-dimensional culture conditioned bone marrow MSC secretome accelerates wound healing in a burn injury mouse model. Biochem Biophys Res Commun. 2023;673:87-95.
Saparov A, Ogay V, Nurgozhin T, Jumabay M, Chen WC. Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response. Stem Cells Int. 2016;2016:3924858.
Flecknell P, Waynforth H. Experimental and surgical technique in the rat. Psicothema. 1995;7(2):452-453.
Israel Y, Quintanilla ME, Ezquer F, et al. Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: role of neuroinflammation-oxidative stress self-perpetuation. Addict Biol. 2019;26:e12853.
Morales P, Fiedler J, Andrés S, et al. Plasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesis. J Neurosci Res. 2008;86(12):2650-2662.
Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther. 2016;7:1-17.
Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106(1):207-212.
Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. Academic Press; 2007.
Perucho J, Gonzalo-Gobernado R, Bazan E, et al. Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC. Amino Acids. 2015;47(5):963-973.
Herrera-Marschitz M, You ZB, Goiny M, et al. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem. 1996;66(4):1726-1735.
Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron. 2004;44(1):161-179.
Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 2002;78(3):637-647.
Li J, Shao D, Jiang D, et al. Alteration of neuroinflammation detected by 18F-GE180 PET imaging in place-conditioned rats with morphine withdrawal. EJNMMI Res. 2021;11(1):1-9.
Skrabalova J, Drastichova Z, Novotny J. Morphine as a potential oxidative stress-causing agent. Mini Rev Org Chem. 2013;10(4):367-372.
Abdel-Zaher AO, Mostafa MG, Farghaly HS, Hamdy MM, Abdel-Hady RH. Role of oxidative stress and inducible nitric oxide synthase in morphine-induced tolerance and dependence in mice. Effect of alpha-lipoic acid. Behav Brain Res. 2013;247:17-26.
Xu N-J, Bao L, Fan H-P, et al. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. J Neurosci. 2003;23(11):4775-4784.
Roberts-Wolfe DJ, Kalivas PW. Glutamate transporter GLT-1 as a therapeutic target for substance use disorders. CNS Neurol Disord Drug Targets. 2015;14(6):745-756.
Mullis K, Perry D, Finn A, Stafford B, Sadee W. Morphine persistence in rat brain and serum after single doses. J Pharmacol Exp Ther. 1979;208(2):228-231.
Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 2012. 12 ed. New York: Mc Graw Hill Lange.
Pergolizzi JV Jr, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management. J Clin Pharm Ther. 2020;45(5):892-903.
Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1(1):13-20.
Darke S, Larney S, Farrell M. Yes, people can die from opiate withdrawal. Addiction. 2017;112:199-200.
Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry. 2019;76(2):208-216.
Gilam G, Sturgeon JA, You DS, Wasan AD, Darnall BD, Mackey SC. Negative affect-related factors have the strongest association with prescription opioid misuse in a cross-sectional cohort of patients with chronic pain. Pain Med. 2020;21(2):e127-e138.
Hua Z, Liu L, Shen J, et al. Mesenchymal stem cells reversed morphine tolerance and opioid-induced hyperalgesia. Sci Rep. 2016;6(1):1-13.
Chen S-L, Tao P-L, Chu C-H, et al. Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol. 2012;7:444-453.
Micheli L, Di Cesare ML, Lucarini E, et al. Intranasal low-dose naltrexone against opioid side effects: a preclinical study. Front Pharmacol. 2020;11:576624.
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-773.
Kim J, Ham S, Hong H, Moon C, Im H-I. Brain reward circuits in morphine addiction. Mol Cells. 2016;39(9):645-653.
Hutchinson MR, Northcutt A, Hiranita T, et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci. 2012;32(33):11187-11200.
Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, Borea PA. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol. 2013;86(4):487-496.
Hutchinson MR, Zhang Y, Shridhar M, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24(1):83-95.
Meng J, Yu H, Ma J, et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One. 2013;8(1):e54040.
Banerjee S, Sindberg G, Wang F, et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9(6):1418-1428.
Jalodia R, Kolli U, Braniff RG, et al. Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis. Gut Microbes. 2022;14(1):2143225.
Hilburger ME, Adler MW, Truant AL, et al. Morphine induces sepsis in mice. J Infect Dis. 1997;176(1):183-188.
Banerjee S, Meng J, Das S, et al. Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a. Sci Rep. 2013;3(1):1977.
Osmanlıoğlu HÖ, Yıldırım MK, Akyuva Y, Yıldızhan K, Nazıroğlu M. Morphine induces apoptosis, inflammation, and mitochondrial oxidative stress via activation of TRPM2 channel and nitric oxide signaling pathways in the hippocampus. Mol Neurobiol. 2020;57:3376-3389.
Shen F, Wang X-W, Ge F-F, Li Y-J, Cui C-L. Essential role of the NO signaling pathway in the hippocampal CA1 in morphine-associated memory depends on glutaminergic receptors. Neuropharmacology. 2016;102:216-228.
Vujić T, Schvartz D, Furlani IL, et al. Oxidative stress and extracellular matrix remodeling are signature pathways of extracellular vesicles released upon morphine exposure on human brain microvascular endothelial cells. Cell. 2022;11(23):3926.
Reymond S, Vujić T, Schvartz D, Sanchez J-C. Morphine-induced modulation of Nrf2-antioxidant response element signaling pathway in primary human brain microvascular endothelial cells. Sci Rep. 2022;12(1):4588.
Rullo L, Caputi FF, Losapio LM, et al. Effects of different opioid drugs on oxidative status and proteasome activity in SH-SY5Y cells. Molecules. 2022;27(23):8321.
Verzillo V, Madia PA, Liu NJ, Chakrabarti S, Gintzler AR. Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine. J Neurochem. 2014;130(6):790-796.
Lacy RT, Strickland JC, Feinstein MA, Robinson AM, Smith MA. The effects of sex, estrous cycle, and social contact on cocaine and heroin self-administration in rats. Psychopharmacology (Berl). 2016;233:3201-3210.
Randesi M, Contoreggi NH, Zhou Y, et al. Sex differences in neuroplasticity-and stress-related gene expression and protein levels in the rat hippocampus following oxycodone conditioned place preference. Neuroscience. 2019;410:274-292.
Famitafreshi H, Karimian M. Socialization alleviates burden of oxidative-stress in hippocampus and prefrontal cortex in morphine addiction period in male rats. Curr Mol Pharmacol. 2018;11(3):254-259.
Bu Q, Yang Y, Yan G, et al. Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. J Proteomics. 2012;75(4):1330-1342.
Samarghandian S, Afshari R, Farkhondeh T. Effect of long-term treatment of morphine on enzymes, oxidative stress indices and antioxidant status in male rat liver. Int J Clin Exp Med. 2014;7(5):1449-1453.
Garcia-Carmona J-A, Camejo DM, Almela P, et al. CP-154,526 modifies CREB phosphorylation and thioredoxin-1 expression in the dentate gyrus following morphine-induced conditioned place preference. PLoS One. 2015;10(8):e0136164.
Sumathi T, Nathiya V, Sakthikumar M. Protective effect of bacoside-A against morphine-induced oxidative stress in rats. Indian J Pharm Sci. 2011;73(4):409-415.
Parekh SV, Adams LO, Barkell GA, Lysle DT. Sex-differences in anxiety, neuroinflammatory markers, and enhanced fear learning following chronic heroin withdrawal. Psychopharmacology (Berl). 2023;240(2):347-359.
Kastl L, Sauer SW, Ruppert T, et al. TNF-α mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-κB activation in liver cells. FEBS Lett. 2014;588(1):175-183.
Ozawa T, Nakagawa T, Shige K, Minami M, Satoh M. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 2001;905(1-2):254-258.
Hsieh JY, Wang HW, Chang SJ, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013;8(8):e72604.
Yari H, Mikhailova MV, Mardasi M, et al. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Res Ther. 2022;13(1):423.
Su Y, Xu C, Cheng W, Zhao Y, Sui L, Zhao Y. Pretreated mesenchymal stem cells and their secretome: enhanced immunotherapeutic strategies. Int J Mol Sci. 2023;24(2):1-38.
Wangler S, Kamali A, Wapp C, et al. Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: a proteomic analysis. Stem Cell Res Ther. 2021;12(1):11.
Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond). 2005;2:8.
Driscoll J, Yan IK, Patel T. Development of a lyophilized off-the-shelf mesenchymal stem cell-derived acellular therapeutic. Pharmaceutics. 2022;14(4):1-11.